Influence of Amifostine on the Toxicity and Pharmacokinetics of Docetaxel in Metastatic Breast Cancer Patients
Preclinical studies suggest that amifostine could protect against toxicities induced by taxoids. We conducted a clinical and pharmacokinetic pilot study to assess the feasibility and toxicity of the docetaxel plus amifostine combination and the absence of influence of amifostine on docetaxel pharmac...
Saved in:
Published in | Clinical cancer research Vol. 8; no. 1; p. 95 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
American Association for Cancer Research
01.01.2002
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!